title: Icodextrin-associated peritonitis: what conclusions thus far?
authors: Division of Nephrology, Université Catholique de Louvain Medical School, 10 Avenue Hippocrate, B-1200 Brussels, Belgium. goffin@nefr.ucl.ac.be
authors: Eric
authors: E
authors: Goffin
authors: Jean-Pierre
authors: JP
authors: Cosyns
authors: Françoise
authors: F
authors: Pirson
authors: Olivier
authors: O
authors: Devuyst
mesh_terms: D015314:Dialysis Solutions / Q000009:adverse effects*; D005936:Glucans / Q000009:adverse effects*; D005947:Glucose / Q000009:adverse effects*; D006801:Humans; D000077607:Icodextrin; D010530:Peritoneal Dialysis / Q000379:methods; D010538:Peritonitis / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology / Q000503:physiopathology*; D015995:Prevalence; D014462:Ultrafiltration / Q000379:methods
chemical_list: D015314:Dialysis Solutions; D005936:Glucans; D000077607:Icodextrin; D005947:Glucose